Support for adjunctive vitamin C treatment in cancer
March 6, 2009Serious flaws in a recent study, which concluded that high doses of vitamin C reduce the effectiveness of chemotherapeutic drugs in the treatment of cancer, are revealed in the current issue of Alternative and Complementary Therapies, a journal published by Mary Ann Liebert, Inc.
In the Medical Journal Watch column of the latest issue, Jack Challem, a personal nutrition coach and nutrition author from Tucson, Arizona, and a regular contributor to the Journal, challenges the findings of a study published in Cancer Research (2008;68:8031-8038), in which the authors conclude that vitamin C given to mice or cultured cells treated with common anti-cancer drugs reduces the antitumor effects of the chemotherapeutic agents.
Challem points out two main problems with the study: the oxidized form of vitamin C (dehydroascorbic acid) and not actual vitamin C (ascorbic acid) was used; and in the mouse experiments, the animals were given toxic doses of dehydroascorbic acid, a compound that is not used as a dietary supplement in humans.
"This study and the subsequent headlines [it generated] were a grievous disservice to physicians and patients with cancer," says Challem. He adds that "considerable positive research…has shown striking benefits from high-dose vitamin C (ascorbic acid) in cancer cells and animals—and in actual human beings."
High-dose intravenous vitamin C is a common form of alternative and complementary therapy for patients receiving chemotherapeutic drugs and is believed to help bring about tumor cell death. In addition, it may promote postsurgical healing by enhancing collagen formation, and increase tissue resistance to tumor spread.
Challem suggests that, "The ideal therapeutic approach would be to tailor individual treatment, including IV vitamin C, from a menu of options."
More information: The report is available free online at http://www.liebertpub.com/act
Source: Mary Ann Liebert
-
Engineers build first sub-10-nm carbon nanotube transistor
Feb 01, 2012 |
4.9 / 5 (31) |
30
-
Something old, something new: Evolution and the structural divergence of duplicate genes
Jan 31, 2012 |
4.6 / 5 (7) |
1
-
The hidden nanoworld of ice crystals: Revealing the dynamic behavior of quasi-liquid layers
Jan 30, 2012 |
5 / 5 (3) |
1
-
Stock market network reveals investor clustering
Jan 27, 2012 |
3.9 / 5 (23) |
8
-
Of microchemistry and molecules: Electronic microfluidic device synthesizes biocompatible probes
Jan 26, 2012 |
5 / 5 (1) |
0
-
Is Everyday Technology Killing Us?
Feb 08, 2012
-
Exercise and weight loss
Feb 08, 2012
-
Why do we have head aches? Our brains can't feel anything.
Feb 07, 2012
-
"The end of diseases" by David Agus, interview from Daily Show with Jon Stewart
Feb 04, 2012
-
Oncolytic adenovirus
Feb 04, 2012
-
Nutrition label stuffs and diets
Feb 02, 2012
- More from Physics Forums - Medical Sciences
More news stories
Complex wiring of the nervous system may rely on a just a handful of genes and proteins
Researchers at the Salk Institute have discovered a startling feature of early brain development that helps to explain how complex neuron wiring patterns are programmed using just a handful of critical genes. ...
13 hours ago |
4.9 / 5 (9) |
1
|
Team isolates nerve cells involved in storing long term memory and gene proteins associated with them
(Medical Xpress) -- A research team in Taiwan has succeeded in isolating two nerve cells in fruit fly brains that are believed to be the major players in allowing for the formation of long term memories. Furthermore, ...
Seeing colors in music, tasting flavors in shapes may happen in life's early months
Famed violinist Itzhak Perlman sees a deep forest green whenever he plays a B-flat on his Stradivarius' G string. The A on the E string is red.
Medicine & Health / Psychology & Psychiatry
20 hours ago |
4.5 / 5 (2) |
2
|
Both maternal and paternal age linked to autism
Older maternal and paternal age are jointly associated with having a child with autism, according to a recently published study led by researchers at The University of Texas Health Science Center at Houston (UTHealth).
Medicine & Health / Psychology & Psychiatry
17 hours ago |
4.3 / 5 (3) |
0
|
New understanding of DNA repair could eventually lead to cancer therapy
A research group in the Faculty of Medicine & Dentistry at the University of Alberta is hoping its latest discovery could one day be used to develop new therapies that target certain types of cancers.
16 hours ago |
4.8 / 5 (6) |
0
|
Anonymous knocks CIA website offline (Update)
The website of the Central Intelligence Agency was inaccessible on Friday after the hacker group Anonymous claimed to have knocked it offline.
New error-correcting codes guarantee the fastest possible rate of data transmission
Error-correcting codes are one of the triumphs of the digital age. Theyre a way of encoding information so that it can be transmitted across a communication channel such as an optical fiber o ...
Humans may have helped the decline of African rainforests 3000 years ago
(PhysOrg.com) -- Large areas of rainforests in Central Africa mysteriously disappeared over three thousand years ago, to be replaced by savannas. The prevailing theory has been that the cause was a change ...
New power source discovered
(PhysOrg.com) -- Researchers at the Massachusetts Institute of Technology (MIT) and RMIT University have made a breakthrough in energy storage and power generation.
Small modular reactor design could be a 'SUPERSTAR'
(PhysOrg.com) -- Though most of today's nuclear reactors are cooled by water, we've long known that there are alternatives; in fact, the world's first nuclear-powered electricity in 1951 came from a reactor ...
The power of estrogen -- male snakes attract other males
A new study has shown that boosting the estrogen levels of male garter snakes causes them to secrete the same pheromones that females use to attract suitors, and turned the males into just about the sexiest ...
Mar 06, 2009
Rank: 2.5 / 5 (2)
The medical cartel and their servants, the FDA, will do everything w/in their power to limit the availability and hide the effectiveness of ANY treatment that might damage their bottom line (or in the case of ca. 75% of the FDA employees, limit the possibility of going to work in the cartel).
Mar 06, 2009
Rank: 1 / 5 (1)
If someone who, you know, ISN'T A QUACK WITH A BOOK DEAL ON THE LINE comes out and bashes this study, I'll listen. Pharmaceutical companies certainly do publish fake studies from time to time for marketing purposes. But this guy doesn't count as such a person.
Mar 06, 2009
Rank: 1 / 5 (2)